fbpx

Tag: developed by the biopharmaceutical Medicago R&D Inc and GlaxoSmithKline (GSK)

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (Anvisa), on Thursday, April 8, authorized Phase 3 trials in Brazil of one more vaccine against Covid-19. The immunizer is being developed by the biopharmaceutical Medicago R&D Inc. from...

LATEST NEWS

WEATHER

Rio de Janeiro
clear sky
14.7 ° C
16 °
12.4 °
88 %
2.6kmh
0 %
Mon
22 °
Tue
21 °
Wed
21 °
Thu
22 °
Fri
22 °
The Rio Times
error: Content is protected !!